Please use this identifier to cite or link to this item: https://apo.ansto.gov.au/dspace/handle/10238/9178
Title: From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use?
Authors: McGregor, IS
Callaghan, PD
Hunt, GE
Keywords: Oxytocin
Drugs
Behavior
Dopamine
Neurology
Social impact
Drug abuse
Brain
Issue Date: 29-Jan-2009
Publisher: The British Pharmacological Society
Citation: McGregor, I. S., Callaghan, P. D., & Hunt, G. E. (2008). From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use?. British journal of pharmacology, 154(2), 358-368. doi:10.1038/bjp.2008.131
Abstract: Addictive drugs can profoundly affect social behaviour both acutely and in the long-term. Effects range from the artificial sociability imbued by various intoxicating agents to the depressed and socially withdrawn state frequently observed in chronic drug users. Understanding such effects is of great potential significance in addiction neurobiology. In this review we focus on the ‘social neuropeptide’ oxytocin and its possible role in acute and long-term effects of commonly used drugs. Oxytocin regulates social affiliation and social recognition in many species and modulates anxiety, mood and aggression. Recent evidence suggests that popular party drugs such as MDMA and gamma-hydroxybutyrate (GHB) may preferentially activate brain oxytocin systems to produce their characteristic prosocial and prosexual effects. Oxytocin interacts with the mesolimbic dopamine system to facilitate sexual and social behaviour, and this oxytocin-dopamine interaction may also influence the acquisition and expression of drug-seeking behaviour. An increasing body of evidence from animal models suggests that even brief exposure to drugs such as MDMA, cannabinoids, methamphetamine and phencyclidine can cause long lasting deficits in social behaviour. We discuss preliminary evidence that these adverse effects may reflect long-term neuroadaptations in brain oxytocin systems. Laboratory studies and preliminary clinical studies also indicate that raising brain oxytocin levels may ameliorate acute drug withdrawal symptoms. It is concluded that oxytocin may play an important, yet largely unexplored, role in drug addiction. Greater understanding of this role may ultimately lead to novel therapeutics for addiction that can improve mood and facilitate the recovery of persons with drug use disorders. © 2019 The British Pharmacological Society
Gov't Doc #: 8812
URI: https://doi.org/10.1038/bjp.2008.132
http://apo.ansto.gov.au/dspace/handle/10238/9178
ISSN: 007-1188
Appears in Collections:Journal Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.